We are live on ! Find out more
PCYC

PHARMACYCLICS INC
PCYC

Delisted

PCYC was delisted on the 22nd of May, 2015.

Back to rankings

1 hedge funds and large institutions have $301K invested in PHARMACYCLICS INC in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 333 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 336 → 1 (-335)

100% less funds holding in top 10

Funds holding in top 10: 41 → 0 (-41)

100% less capital invested

Capital invested by funds: $14.3B → $301K (-$14.3B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 333

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-335
Holders Change %
-99.7%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-41
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
333
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$2.46B
2
BBA
Baker Bros. Advisors
New York
-$2.31B
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1B
4
Primecap Management
Primecap Management
California
-$585M
5
PCM
Pentwater Capital Management
Florida
-$572M
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
201
Amalgamated Bank
New York
– -$1.76M -6,887 Closed
LS
202
Livforsakringsbolaget Skandia
Sweden
– -$1.75M -6,818 Closed
KM
203
KS Management
New York
– -$1.74M -6,800 Closed
NMIMC
204
Northwestern Mutual Investment Management Company
Wisconsin
– -$1.73M -6,740 Closed
AAF
205
Andra AP-fonden
Sweden
– -$1.72M -6,700 Closed
AAM
206
Advisors Asset Management
Colorado
– -$1.64M -6,417 Closed
VIA
207
Vident Investment Advisory
Georgia
– -$1.64M -6,403 Closed
Nomura Asset Management
208
Nomura Asset Management
Japan
– -$1.63M -6,380 Closed
HHC
209
Hutchin Hill Capital
New York
– -$1.62M -6,321 Closed
TI
210
TT International
United Kingdom
– -$1.53M -6,001 Closed
M&T Bank
211
M&T Bank
New York
– -$1.51M -5,906 Closed
SAM
212
Shell Asset Management
Netherlands
– -$1.44M -5,635 Closed
CA
213
Commerzbank Aktiengesellschaft
Germany
– -$1.35M -5,264 Closed
SG Americas Securities
214
SG Americas Securities
New York
– -$1.31M -5,138 Closed
FANJ
215
Financial Architects (New Jersey)
New Jersey
– -$1.28M -5,000 Closed
LOAMU
216
Lombard Odier Asset Management (USA)
New York
– -$1.28M -5,000 Closed
New York State Common Retirement Fund
217
New York State Common Retirement Fund
New York
– -$1.28M -5,000 Closed
AL
218
Airain Ltd
Guernsey
– -$1.26M -4,940 Closed
WRBC
219
W.R. Berkley Corp
Connecticut
– -$1.23M -4,793 Closed
NG
220
NatWest Group
United Kingdom
– -$1.2M -4,698 Closed
SMDAM
221
Sumitomo Mitsui DS Asset Management
Japan
– -$1.2M -4,679 Closed
FWCM
222
First Western Capital Management
California
– -$1.19M -4,655 Closed
OAM
223
Orinda Asset Management
California
– -$1.15M -4,500 Closed
AG
224
Aperio Group
California
– -$1.15M -4,476 Closed
BF
225
BOK Financial
Oklahoma
– -$1.11M -4,340 Closed
7 8
9
10 11

PCYC Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in PHARMACYCLICS INC (PCYC) for Q2 2015, worth a combined $301K — down 100% from $14.3B a quarter earlier.

Sellers outnumbered buyers: 333 funds closed out of PCYC and 0 opened new positions — a net loss of 333 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $2.46B sold.

  • 1 institutional investor held PHARMACYCLICS INC (PCYC) as of Q2 2015, down from 336 in Q1 2015.
  • Funds reported $301K of PHARMACYCLICS INC stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new PHARMACYCLICS INC positions in Q2 2015 and 333 closed out, a net change of -333 holders.
  • The largest PHARMACYCLICS INC seller in Q2 2015 was T. Rowe Price Associates, an estimated $2.46B sold.

Based on aggregated 13F filings for Q2 2015.